Suggestions
Tehila Ben-Moshe
Founder, CEO and chairman Biond Biologics
Tehila Ben-Moshe is a highly accomplished professional in the biotechnology and biopharmaceutical sectors, with a strong academic foundation that has paved the way for her impressive career. With a PhD in Biological Chemistry from the prestigious Weizmann Institute of Science, she has cultivated a deep understanding of the intricate science that underpins biotechnology and drug development. Her expertise is bolstered by a Master of Science in Biology from Bar-Ilan University and a Bachelor of Science degree in Biotechnology from the Robert H. Smith Faculty of Agriculture, Food and Environment at the Hebrew University of Jerusalem. Tehila's educational background illustrates her commitment to academic excellence and her dedication to advancing the field of biological sciences.
Tehila's professional journey is marked by her leadership and innovative contributions to the biotechnology industry. As the Chief Executive Officer at Biond Biologics Ltd, she has been at the forefront of developing cutting-edge biologics that aim to revolutionize treatment options for patients. Under her guidance, Biond Biologics has focused on creating novel therapies that have the potential to address critical unmet medical needs, highlighting her vision to integrate scientific research with practical therapeutic applications.
Before her tenure at Biond Biologics, Tehila served as the Chief Executive Officer at cCAM Biotherapeutics, where she led the company's strategic direction and operations. Her leadership was instrumental in advancing cCAM's innovative therapeutic programs, showcasing her ability to drive growth and bring forward-thinking solutions to the biotherapeutics space. This position further exemplifies Tehila's prowess in navigating the complexities of the biopharmaceutical landscape, making her a respected figure among her peers.
Additionally, Tehila’s experience includes a significant role as a Project Manager at Protalix Biotherapeutics, where she was involved in managing various projects aimed at developing transformative therapies based on innovative production technologies. Her ability to manage high-stake projects and collaborate effectively with multidisciplinary teams reflects her exceptional organizational skills and commitment to seeing projects through from conception to fruition.
Tehila Ben-Moshe’s contributions to the biotechnology field extend beyond her roles in leadership. Her commitment to research and development, coupled with her robust academic background, positions her as a thought leader in the intersection of science and practical therapeutic solutions. Through her various leadership roles, Tehila has demonstrated an unwavering dedication to advancing healthcare and ensuring that innovative solutions reach those in need. Her ongoing work is a testament to her belief in the power of biotechnology to create a meaningful impact on global health challenges.
